Author:
Fernandez Anthony P.,Ellis Ariana,Khanna Urmi,Galadari AbdulAziz
Reference8 articles.
1. Low conversion rate of QuantiFERON-TB Gold screening tests in patients treated with tumor necrosis factor inhibitors: a retrospective cohort study identifying an important practice gap;Chung;J Am Acad Dermatol,2018
2. Conversion to positive latent tuberculosis infection status is low in hidradenitis suppurativa patients taking biologic medications;Ellis;J Am Acad Dermatol,2020
3. Conversion of tuberculosis screening tests during biologic therapy among veteran patient population with rheumatic disease;Pattanaik;ACR Open Rheumatol,2019
4. Healthmonix. 2019 MIPS Measure #337: Psoriasis: Tuberculosis (TB) Prevention for Patients with Psoriasis, Psoriatic Arthritis and Rheumatoid Arthritis on a Biological Immune Response Modifier. http://healthmonix.com/mips_quality_measure/2019-mips-quality-measure-337/. Accessed March 12, 2020.
5. Unites Heathcare. Specialty Medication Prior Authorization Cover Sheet. https://www.uhcprovider.com/content/dam/provider/docs/public/prior-auth/uhccp-pharmacy-forms/h-l/MI-Humira-Prior-Authorization-Form.pdf. Accessed March 12, 2020.